Rayence

레이언스 · 228850

Health Care Medical Devices · KOSDAQ

Small-cap

Market cap US$79.2M (₩109.3B)

Overview

Rayence makes digital X-ray detectors, sensors that capture X-ray images and convert them into digital pictures used by doctors, dentists, veterinarians, and industrial operators.

Its products cover a full range of applications, from medical and dental imaging to animal care and industrial inspection, and it also develops the image-processing software that works alongside its hardware. Listed on KOSDAQ, Korea's tech-focused stock exchange, the company's detector portfolio spans two core sensor technologies: a thin-film transistor type for still images and large-area sensing, and a CMOS type for high-resolution video imaging.

Summary is AI-generated and may contain errors · figures from DART filings

Financials

Source: DART · FY ending Dec · latest FY2025

Revenue · FY2025

US$83.1M

▼ −8.6% YoY

Operating profit · FY2025

−US$2.9M

Turned to loss

Net income · FY2025

−US$3.9M

Turned to loss

Revenue, operating profit and net income by fiscal year (USD; KRW in parentheses).
Metric	FY2023	FY2024	FY2025
Revenue	US$103.6M(₩143B)	US$91M(₩125.6B)	US$83.1M(₩114.7B)
Operating profit	US$14.3M(₩19.7B)	US$4.8M(₩6.6B)	−US$2.9M(−₩4B)
Net income	US$14.1M(₩19.5B)	US$5.6M(₩7.7B)	−US$3.9M(−₩5.3B)

Revenue

FY2023US$103.6M
FY2024US$91M
FY2025US$83.1M

Operating profit

FY2023US$14.3M
FY2024US$4.8M
FY2025−US$2.9M

Net income

FY2023US$14.1M
FY2024US$5.6M
FY2025−US$3.9M

Key ratios (FY2025)

ROE

-2.2%

Debt/Eq

10.1%

Op. margin

-3.4%

Net margin

-4.6%

Rev. YoY

▼ −8.6%

Why it matters

Rayence has extended into the veterinary market through subsidiaries Wooriyen and Wooriyen Farm, and operates sales and R&D entities in Mexico and the United States.

Price charts coming soon

Interactive price history isn't here yet. Would you use it?